Annual Interest Expense
$866.60 K
+$111.20 K+14.72%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual interest expense is currently $866.60 thousand, with the most recent change of +$111.20 thousand (+14.72%) on 31 December 2023. During the last 3 years, it has fallen by -$537.80 thousand (-38.29%). EPRX annual interest expense is now -38.29% below its all-time high of $1.40 million, reached on 01 December 2020.EPRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$500.00
-$281.30 K-99.82%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly interest expense is currently $500.00, with the most recent change of -$281.30 thousand (-99.82%) on 01 September 2024. Over the past year, it has dropped by -$320.00 thousand (-99.84%). EPRX quarterly interest expense is now -99.88% below its all-time high of $410.90 thousand, reached on 01 December 2019.EPRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$859.90 K
-$320.00 K-27.12%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock TTM interest expense is currently $859.90 thousand, with the most recent change of -$320.00 thousand (-27.12%) on 01 September 2024. Over the past year, it has dropped by -$359.20 thousand (-29.46%). EPRX TTM interest expense is now -41.26% below its all-time high of $1.46 million, reached on 01 September 2020.EPRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | -99.8% | -29.5% |
| 3 y3 years | -38.3% | -99.8% | -25.4% |
| 5 y5 years | +690.0% | -99.8% | +210.2% |
EPRX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.3% | +14.7% | -99.8% | at low | -29.5% | at low |
| 5 y | 5 years | -38.3% | +690.0% | -99.9% | at low | -41.3% | +210.2% |
| alltime | all time | -38.3% | +2029.2% | -99.9% | at low | -41.3% | +210.2% |
Eupraxia Pharmaceuticals Common Stock Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $500.00(-99.8%) | $859.90 K(-27.1%) |
| June 2024 | - | $281.80 K(-12.2%) | $1.18 M(-1.7%) |
| Mar 2024 | - | $321.10 K(+25.2%) | $1.20 M(+2.5%) |
| Dec 2023 | $866.60 K(+14.7%) | $256.50 K(-20.0%) | $1.17 M(-4.0%) |
| Sept 2023 | - | $320.50 K(+6.2%) | $1.22 M(+6.1%) |
| June 2023 | - | $301.80 K(+3.5%) | $1.15 M(+1.3%) |
| Mar 2023 | - | $291.50 K(-4.5%) | $1.13 M(+2.1%) |
| Dec 2022 | $755.40 K(-27.0%) | - | - |
| Dec 2022 | - | $305.30 K(+22.1%) | $1.11 M(+3.8%) |
| Sept 2022 | - | $250.00 K(-12.8%) | $1.07 M(-0.4%) |
| June 2022 | - | $286.80 K(+7.0%) | $1.07 M(+14.8%) |
| Mar 2022 | - | $268.00 K(+1.4%) | $934.70 K(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.03 M(-26.4%) | $264.20 K(+4.0%) | $1.02 M(-11.1%) |
| Sept 2021 | - | $254.00 K(+71.0%) | $1.15 M(-3.5%) |
| June 2021 | - | $148.50 K(-58.5%) | $1.19 M(-15.5%) |
| Mar 2021 | - | $358.20 K(-8.6%) | $1.41 M(-2.2%) |
| Dec 2020 | $1.40 M(+27.3%) | $391.90 K(+32.4%) | $1.44 M(-1.3%) |
| Sept 2020 | - | $295.90 K(-19.4%) | $1.46 M(+1.3%) |
| June 2020 | - | $366.90 K(-6.0%) | $1.45 M(+34.0%) |
| Mar 2020 | - | $390.20 K(-5.0%) | $1.08 M(+56.7%) |
| Dec 2019 | $1.10 M(+905.4%) | $410.90 K(+48.2%) | $688.10 K(+148.2%) |
| Sept 2019 | - | $277.20 K | $277.20 K |
| Dec 2018 | $109.70 K(+169.5%) | - | - |
| Dec 2017 | $40.70 K | - | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual interest expense?
- What is the all time high annual interest expense for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual interest expense year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly interest expense?
- What is the all time high quarterly interest expense for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly interest expense year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock TTM interest expense?
- What is the all time high TTM interest expense for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock TTM interest expense year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual interest expense?
The current annual interest expense of EPRX is $866.60 K
What is the all time high annual interest expense for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual interest expense is $1.40 M
What is Eupraxia Pharmaceuticals Common Stock annual interest expense year-on-year change?
Over the past year, EPRX annual interest expense has changed by +$111.20 K (+14.72%)
What is Eupraxia Pharmaceuticals Common Stock quarterly interest expense?
The current quarterly interest expense of EPRX is $500.00
What is the all time high quarterly interest expense for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly interest expense is $410.90 K
What is Eupraxia Pharmaceuticals Common Stock quarterly interest expense year-on-year change?
Over the past year, EPRX quarterly interest expense has changed by -$320.00 K (-99.84%)
What is Eupraxia Pharmaceuticals Common Stock TTM interest expense?
The current TTM interest expense of EPRX is $859.90 K
What is the all time high TTM interest expense for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high TTM interest expense is $1.46 M
What is Eupraxia Pharmaceuticals Common Stock TTM interest expense year-on-year change?
Over the past year, EPRX TTM interest expense has changed by -$359.20 K (-29.46%)